Aurangabad, India

Kandepu Sreenivas

This inventor holds 4 USPTO granted patents. Top assignee: Wockhardt Limited. Active years: 2005-2009.


Average Co-Inventor Count = 9.1

ph-index = 2

Forward Citations = 47(Granted Patents)


Location History:

  • Cidco, IN (2005)
  • Aurangabad, IN (2005 - 2009)

Company Filing History:


Years Active: 2005-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kandepu Sreenivas: Innovator in Antimicrobial Research

Introduction

Kandepu Sreenivas is a notable inventor based in Aurangabad, India. He has made significant contributions to the field of antimicrobial research, holding a total of 4 patents. His work focuses on developing innovative solutions to combat bacterial infections.

Latest Patents

One of his latest patents is titled "Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments." This invention relates to new generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives. It also encompasses their optical isomers, diastereomers, or enantiomers, as well as pharmaceutically acceptable salts, hydrates, prodrugs, polymorphs, and pseudopolymorphs. The patent details their preparation, compositions, and medicinal uses.

Career Highlights

Kandepu Sreenivas is currently associated with Wockhardt Limited, a prominent pharmaceutical company. His role involves extensive research and development in the field of antimicrobial agents. His innovative approach has led to advancements in the effectiveness of these compounds.

Collaborations

He has collaborated with notable colleagues such as Noel John De Souza and Mahesh Vithalbhai Patel. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Kandepu Sreenivas is a distinguished inventor whose work in antimicrobial research has the potential to significantly impact healthcare. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…